Literature DB >> 8804528

Parallel-compound synthesis: methodology for accelerating drug discovery.

C N Selway1, N K Terrett.   

Abstract

Parallel compound synthesis enables large numbers of individual compounds to be prepared simultaneously using semiautomated techniques. This fast and efficient methodology has an important role to play in accelerating lead optimisation and hence the whole drug discovery process. The potential of this strategy to rapidly optimise chemical leads and provide structure-activity relationship (SAR) information was demonstrated in two therapeutic areas, antiviral agents (herpes simplex virus), and neurokinin-2 receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8804528     DOI: 10.1016/0968-0896(96)00058-2

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Pharmacophore and receptor models for neurokinin receptors.

Authors:  Anders Poulsen; Berith Bjørnholm; Klaus Gundertofte; Irina D Pogozheva; Tommy Liljefors
Journal:  J Comput Aided Mol Des       Date:  2003-11       Impact factor: 3.686

Review 2.  Advances in microwave-assisted combinatorial chemistry without polymer-supported reagents.

Authors:  Rafael Martínez-Palou
Journal:  Mol Divers       Date:  2006-08-01       Impact factor: 2.943

3.  A pharmacophore model for NK2 antagonist comprising compounds from several structurally diverse classes.

Authors:  Anders Poulsen; Tommy Liljefors; Klaus Gundertofte; Berith Bjørnholm
Journal:  J Comput Aided Mol Des       Date:  2002-04       Impact factor: 3.686

4.  A New Application of Parallel Synthesis Strategy for Discovery of Amide-Linked Small Molecules as Potent Chondroprotective Agents in TNF-α-Stimulated Chondrocytes.

Authors:  Chia-Chung Lee; Yang Lo; Ling-Jun Ho; Jenn-Haung Lai; Shiu-Bii Lien; Leou-Chyr Lin; Chun-Liang Chen; Tsung-Chih Chen; Feng-Cheng Liu; Hsu-Shan Huang
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.